Defects in aminoacyl tRNA synthetases are linked to various human diseases, including neurological disorders and cancer. Understanding the catalytic mechanisms of these enzymes can lead to the development of therapeutic agents that target specific aaRS. Inhibitors of aaRS are also being explored as potential antibiotics, given their crucial role in bacterial protein synthesis.
